Total Payments
$12,695
2024 Payments
$245.14
Companies
24
Transactions
114
Medicare Patients
6,064
Medicare Billing
$612,561
Payment Breakdown by Category
Consulting$4,500 (35.4%)
Research$3,530 (27.8%)
Food & Beverage$2,984 (23.5%)
Travel$1,681 (13.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,500 | 1 | 35.4% |
| Unspecified | $3,530 | 2 | 27.8% |
| Food and Beverage | $2,984 | 102 | 23.5% |
| Travel and Lodging | $1,681 | 9 | 13.2% |
Payments by Type
General
$9,165
112 transactions
Research
$3,530
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Flexion Therapeutics, Inc. | $5,741 | 10 | $0 (2018) |
| PFIZER INC. | $3,813 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,010 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $402.41 | 6 | $0 (2023) |
| Amgen Inc. | $259.81 | 12 | $0 (2024) |
| Genentech, Inc. | $252.60 | 2 | $0 (2022) |
| Novo Nordisk Inc | $227.62 | 12 | $0 (2021) |
| ABBVIE INC. | $165.22 | 3 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $152.99 | 9 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $140.87 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.14 | 7 | Johnson & Johnson Health Care Systems Inc. ($125.72) |
| 2023 | $3,618 | 12 | PFIZER INC. ($3,200) |
| 2022 | $610.08 | 8 | PFIZER INC. ($330.00) |
| 2021 | $13.26 | 1 | Novo Nordisk Inc ($13.26) |
| 2020 | $92.72 | 5 | Merck Sharp & Dohme Corporation ($38.26) |
| 2019 | $353.18 | 13 | AbbVie, Inc. ($116.44) |
| 2018 | $6,227 | 36 | Flexion Therapeutics, Inc. ($5,741) |
| 2017 | $1,536 | 32 | Novartis Pharmaceuticals Corporation ($978.00) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Analgesic | ||||||
| 03/28/2024 | Johnson & Johnson Health Care Systems Inc. | STELARA (Biological), DARZALEX | Food and Beverage | In-kind items and services | $125.72 | General |
| Category: Immunology | ||||||
| 03/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiology | ||||||
| 01/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Inflammation | ||||||
| 12/21/2023 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: PF07038124 CLINICAL PUBLICATION PROGRAM | ||||||
| 11/14/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Bone Health | ||||||
| 10/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Inflammation | ||||||
| 09/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Bone Health | ||||||
| 09/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Oncology | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $95.21 | General |
| Category: Respiratory | ||||||
| 08/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 06/15/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Bone Health | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.37 | General |
| Category: Respiratory | ||||||
| 09/29/2022 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 08/10/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Immunology | ||||||
| 07/12/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/06/2022 | Genentech, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $144.72 | General |
| Category: Immunology | ||||||
| 03/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2022 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $39.80 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PF07038124 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,039 | 1,492 | $309,129 | $118,055 |
| 2022 | 7 | 1,074 | 1,639 | $371,081 | $144,454 |
| 2021 | 14 | 1,799 | 2,443 | $441,809 | $179,177 |
| 2020 | 18 | 2,152 | 2,962 | $417,058 | $170,874 |
Total Patients
6,064
Total Services
8,536
Medicare Billing
$612,561
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 279 | 711 | $189,837 | $62,653 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 191 | 191 | $46,604 | $24,575 | 52.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 234 | 234 | $42,120 | $18,640 | 44.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 19 | $9,215 | $4,245 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 36 | $6,840 | $2,145 | 31.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,839 | $1,850 | 48.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 163 | 173 | $6,228 | $1,799 | 28.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 81 | 81 | $3,078 | $1,482 | 48.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 36 | 36 | $1,368 | $666.72 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 833 | $225,591 | $74,093 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 231 | 231 | $56,364 | $30,632 | 54.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 255 | 258 | $46,440 | $21,684 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 88 | $16,793 | $6,887 | 41.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 27 | $13,095 | $6,206 | 47.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 18 | $6,174 | $2,979 | 48.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 173 | 184 | $6,624 | $1,973 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 292 | 774 | $211,276 | $77,757 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 250 | 250 | $61,000 | $34,400 | 56.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 278 | 280 | $50,400 | $23,853 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 180 | 223 | $41,718 | $11,556 | 27.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 157 | 232 | $20,416 | $7,285 | 35.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 27 | 30 | $14,550 | $6,696 | 46.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 253 | 253 | $9,614 | $4,807 | 50.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 230 | 254 | $9,144 | $2,776 | 30.4% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 58 | 69 | $7,038 | $2,718 | 38.6% |
About Dr. Robert Levin, MD
Dr. Robert Levin, MD is a Internal Medicine healthcare provider based in Wellington, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972543221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Levin, MD has received a total of $12,695 in payments from pharmaceutical and medical device companies, with $245.14 received in 2024. These payments were reported across 114 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($4,500).
As a Medicare-enrolled provider, Levin has provided services to 6,064 Medicare beneficiaries, totaling 8,536 services with total Medicare billing of $612,561. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wellington, FL
- Active Since 06/07/2006
- Last Updated 11/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972543221
Products in Payments
- Zilretta (Drug) $5,741
- COSENTYX (Biological) $978.00
- FASENRA (Biological) $220.58
- XELJANZ (Drug) $198.47
- BYDUREON (Drug) $163.35
- Victoza (Drug) $162.61
- Actemra (Biological) $144.72
- JANUVIA (Drug) $141.69
- ORENCIA (Biological) $140.87
- STELARA (Biological) $125.72
- Humira (Biological) $116.44
- TRULICITY (Drug) $66.82
- Prolia (Biological) $65.21
- Ozempic (Drug) $65.01
- Repatha (Biological) $45.10
- JARDIANCE (Drug) $44.93
- Cologuard Collection Kit (Device) $43.59
- EVENITY (Biological) $42.23
- Otezla (Drug) $38.96
- MOUNJARO (Drug) $36.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wellington
Dr. Jeffrey Collins, M.d, M.D
Internal Medicine — Payments: $34,062
Internal Medicine $34,062
Dr. Atif Bashir, M.d, M.D
Internal Medicine — Payments: $16,022
Internal Medicine $16,022
Dr. Mounir Wassef, D.o, D.O
Internal Medicine — Payments: $11,400
Internal Medicine $11,400
Juan Zapata, M.d, M.D
Internal Medicine — Payments: $10,875
Internal Medicine $10,875
Dr. Maria Sukhoo, Do, DO
Internal Medicine — Payments: $8,891
Internal Medicine $8,891
Dr. Shekhar Sharma, M.d, M.D
Internal Medicine — Payments: $8,836
Internal Medicine $8,836